Sodium–glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresisHarindra Rajasekeran, David Z.I. Cherney, Yuliya Lytvyn|Kidney International|2016Cited by 130
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot studyHarindra Rajasekeran, David Z.I. Cherney, Leslie Cham et al.|American Journal of Physiology-Renal Physiology|2017Cited by 87
Urinary adenosine excretion in type 1 diabetesHarindra Rajasekeran, David Z.I. Cherney, Yuliya Lytvyn et al.|American Journal of Physiology-Renal Physiology|2017Cited by 57
The Effect of SGLT2 Inhibition on Urinary Adenosine Excretion in Patients with Type 1 DiabetesHarindra Rajasekeran, David Cherney, Yuliya Lytvyn et al.|Canadian Journal of Diabetes|2016Cited by 4
Estimating Glomerular Filtration Rate Calculated by Serum Creatinine Lacks Precision and Accuracy in Adults with Type 2 Diabetes with Preserved Renal FunctionJulie A. Lovshin, David Z.I. Cherney, Petter Bjornstad et al.|Diabetes|2018Cited by 0